02-00-2023
Polish startup IQ Biozoom is revolutionizing home health diagnostics with its cutting-edge saliva-based testing technology. The company has developed a device that measures biochemical substances like glucose and lactates non-invasively, eliminating the need for finger-prick blood tests. This innovation offers a painless and accurate alternative for monitoring chronic conditions, such as diabetes, from the comfort of home.
IQ Biozoom's technology involves advanced biosensors that analyze saliva samples with laboratory precision. The company is currently seeking investment to finalize the development and certification of their device. The device also aims to detect additional biomarkers, including cholesterol, hormones, and CRP proteins, in the future.
Founded in Stalowa Wola, IQ Biozoom has gained recognition as a finalist in prestigious competitions such as the EIT Health InnoStars Awards and MIT Enterprise Forum CEE. The technology, which has been patented in Europe, the USA, and China, represents a significant advancement in personal healthcare, increasing accessibility to diagnostic testing and supporting the move towards personalized medicine.
For more details, you can read the full article here.
IQ Biozoom introduces revolutionary medical innovations with its biosensing platform. We develop non-invasive, pain-free saliva-based tests to monitor various civilisation diseases, providing easy access to health information.
Get more info about IQ Biozoom Technology
Interesting in our science publications? Contact us to get the links.
Meet us:
